摘要: |
将泰地罗新注射液分为高、中、低(8、4、2 mg /kg bw)3个剂量组分别肌肉注射治疗猪传染性胸膜肺炎,同时设默沙东动物保健品有限公司的泰地罗新注射液为对照组,按4mg /kg bw给药,给药一次。结果表明,泰地罗新注射液中(4mg/kg bw)、高(8mg/kg bw)剂量对人工感染传染性胸膜肺炎病猪的有效率和治愈率无显著差异(P>0.05),与默沙东动物保健品有限公司生产的泰地罗新注射液推荐剂量(4mg/kg bw)的效果相当。试验结果表明泰地罗新注射液按一次量,每1 kg体重4mg肌注,对猪传染性胸膜肺炎有良好的治疗效果。 |
关键词: 泰地罗新注射液 猪 传染性胸膜肺炎 临床疗效 |
DOI: |
投稿时间:2022-02-14修订日期:2022-06-30 |
基金项目: |
|
Clinical effect of Tildipirosin injection on porcine infectious pleuropneumonia |
|
() |
Abstract: |
Tildipirosin injection was divided into three groups of high, medium and low doses (8, 4, 2 mg /kg BW) for the treatment of porcine infectious pleuropneumonia by intramuscular injection. Meanwhile, Tildipirosin injection from MSD Animal Health Products Co., LTD was set as the control group, and was given 4mg /kg BW once. The results showed that there was no significant difference in the effective rate and cure rate between medium (4mg/kg BW) and high (8mg/kg BW) doses of Tildipirosin injection in artificially infected pigs with infectious pleuralpneumonia (P>0.05), which was similar to the recommended dose of Tidiloxin injection produced by MSD Animal Health Products Co., LTD. (4mg/kg BW).The results showed that Tildipirosin injection has a good therapeutic effect on porcine infectious pleuropneumonia by intramuscular injection of 4mg per 1 kg body weight. |
Key words: Tildipirosin injection porcine infectious pleuropneumonia clinical effect |